Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04258020 · ClinicalTrials.gov registry record · NA
Postextubation Management in Patients at Risk for Extubation Failure
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04258020 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 6 participants.
The verdict
NCT04258020, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
At the time of weaning from mechanical ventilation, patients with heart and/or lung conditions will be given oxygen support with alternating bilevel positive airway pressure (BiPAP; oxygen via face mask) and heated high flow nasal cannula oxygen (HFNC; oxygen via nasal cannula) to see if this method reduces the likelihood of re-intubation.
Interventions
- DEVICE HFNC
- DEVICE BiPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-02-11 |
| Est. Completion | 2020-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04258020
The ClinicalTrials.gov registry entry for NCT04258020 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HFNC is the first listed.
NCT04258020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04258020 about?
NCT04258020 is a clinical study titled "Postextubation Management in Patients at Risk for Extubation Failure". At the time of weaning from mechanical ventilation, patients with heart and/or lung conditions will be given oxygen support with alternating bilevel positive airway pressure (BiPAP; oxygen via face mask) and heated high flow nasal cannula oxygen (HFNC; oxygen via nasal cannula) to see if this method...
What is the current status of trial NCT04258020?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2020-02-11. Estimated completion is 2020-04-02.
What interventions are being tested in trial NCT04258020?
The interventions under investigation include: HFNC (DEVICE), BiPAP (DEVICE).
Who is sponsoring clinical trial NCT04258020?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.